TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Codexis Inc (CDXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 148 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CDXS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
48 45 36 54 78 149 222 246 250 137 149 148
33 33 27 45 67 114 184 162 163 93 99 97
26 23 19 31 53 90 149 117 114 65 19 51
26 23 19 31 53 90 150 117 114 65 73 78
3.9 7.3 5.9 12 13 20 29 38 41 20 19 11
1.4 1.0 0.8 1.0 0.6 0.4 1.0 1.2 2.0 2.7 1.8 1.8
4.0 3.1 2.2 2.8 4.8 6.3 9.7 65 62
3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 2.5 2.5 2.5
6.2 2.8 3.2 3.2
22 22 17 29 22 44 52 82 106 50 82 97
14 15 12 25 17 15 25 33 49 36 24 25
0.4 0.4 0.4 0.4 1.2 2.6 4.1 5.4 3.8 2.8 2.9
4.7 3.4 4.2 3.5 3.1 2.6 3.0 3.0 3.2 5.9 2.8 1.6
0.0 0.0 0.0 0.3 29 40
26 23 19 25 56 106 170 164 145 87 67 51
-276 -284 -292 -315 -330 -342 -366 -388 -421 -498 -563 -607
38 39 41 46 52 57 59 65 65 68 73 87

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?